JBC Focus on PI3-Kinase with Echelon

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


A more recent version of this article appeared on April 19, 2002
This Article
Right arrow Full Text (Accepted Manuscript)
Right arrow All Versions of this Article:
277/17/15171    most recent
M200349200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wilson, M. A.
Right arrow Articles by Archer, T. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wilson, M. A.
Right arrow Articles by Archer, T. K.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Papers In Press, published online ahead of print January 30, 2002
J. Biol. Chem, 10.1074/jbc.M200349200
Submitted on January 11, 2002
Revised on January 28, 2002
Accepted on January 28, 2002

The histone deacetylase inhibitor TSA blocks progesterone receptor-mediated transactivation of the MMTV promoter in vivo

Melissa A. Wilson, Bonnie J. Deroo, Andrea R. Ricci, and Trevor K. Archer

Laboratory of Reproductive and Developmetal Toxicology, National Institute of Environmental Health Sciences, Research Triangle Park, NC 27709

Corresponding Author: archer1{at}niehs.nih.gov

Post-translational modifications of histones play an important role in modulating gene transcription within chromatin. We used the mouse mammary tumor virus (MMTV) promoter, which adopts an ordered, nucleosomal structure, to investigate the impact of a specific inhibitor of histone deacetylase, Trichostatin-A (TSA), on progesterone receptor (PR) activated transcription. TSA induced global histone hyperacetylation and this effect occurred independent of the presence of hormone. Interestingly, chromatin immunoprecipitation analysis revealed no significant change in the level of acetylated histones associated with the MMTV promoter following high TSA treatment. In human breast cancer cells where the MMTV promoter adopts a constitutively "open" chromatin structure, treatment with TSA converted the MMTV promoter into a closed structure. Addition of hormone did not overcome this TSA-induced closure of the promoter chromatin. Furthermore, TSA treatment resulted in the eviction of the transcription factor nuclear factor 1 (NF1) from the promoter and reduced PR-induced transcription. Kinetic experiments revealed that a loss of chromatin remodeling proteins was coincident with the decrease in MMTV transcriptional activity and the imposition of repressed chromatin architecture at the promoter. These results demonstrate that deacetylase inhibitor treatment at levels that induce global histone acetylation may leave specific regulatory regions relatively unaffected, and that this treatment may lead to transcriptional inhibition by mechanisms that modify chromatin remodeling proteins rather than by influencing histone acetylation of the local promoter chromatin structure.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
P. B. Hebbar and T. K. Archer
Altered Histone H1 Stoichiometry and an Absence of Nucleosome Positioning on Transfected DNA
J. Biol. Chem., February 22, 2008; 283(8): 4595 - 4601.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
S. Aoyagi and T. K. Archer
Dynamic Histone Acetylation/Deacetylation with Progesterone Receptor-Mediated Transcription
Mol. Endocrinol., April 1, 2007; 21(4): 843 - 856.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
Z. Yu and B. C. Kone
Targeted histone H4 acetylation via phosphoinositide 3-kinase- and p70s6-kinase-dependent pathways inhibits iNOS induction in mesangial cells
Am J Physiol Renal Physiol, February 1, 2006; 290(2): F496 - F502.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
B. F. Clem and B. J. Clark
Association of the mSin3A-Histone Deacetylase 1/2 Corepressor Complex with the Mouse Steroidogenic Acute Regulatory Protein Gene
Mol. Endocrinol., January 1, 2006; 20(1): 100 - 113.
[Abstract] [Full Text] [PDF]


Home page
J EndocrinolHome page
A. G Gunin, I. N Kapitova, and N. V Suslonova
Effects of histone deacetylase inhibitors on estradiol-induced proliferation and hyperplasia formation in the mouse uterus
J. Endocrinol., June 1, 2005; 185(3): 539 - 549.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
X. Tong, L. Yin, S. Joshi, D. W. Rosenberg, and C. Giardina
Cyclooxygenase-2 Regulation in Colon Cancer Cells: MODULATION OF RNA POLYMERASE II ELONGATION BY HISTONE DEACETYLASE INHIBITORS
J. Biol. Chem., April 22, 2005; 280(16): 15503 - 15509.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
B. A. Burkhart, P. B. Hebbar, K. W. Trotter, and T. K. Archer
Chromatin-dependent E1A Activity Modulates NF-{kappa}B RelA-mediated Repression of Glucocorticoid Receptor-dependent Transcription
J. Biol. Chem., February 25, 2005; 280(8): 6349 - 6358.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Chang and C. S. Pikaard
Transcript Profiling in Arabidopsis Reveals Complex Responses to Global Inhibition of DNA Methylation and Histone Deacetylation
J. Biol. Chem., January 7, 2005; 280(1): 796 - 804.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
D. Y. L. Mao, D. Barsyte-Lovejoy, C. S. W. Ho, J. D. Watson, A. Stojanova, and L. Z. Penn
Promoter-binding and repression of PDGFRB by c-Myc are separable activities
Nucleic Acids Res., June 29, 2004; 32(11): 3462 - 3468.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. Botos, W. Xian, D. F. Smith, and C. L. Smith
Progesterone Receptor Deficient in Chromatin Binding Has an Altered Cellular State
J. Biol. Chem., April 9, 2004; 279(15): 15231 - 15239.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
D. Obradovic, M. Tirard, Zs. Nemethy, O. Hirsch, H. Gronemeyer, and O. F. X. Almeida
DAXX, FLASH, and FAF-1 Modulate Mineralocorticoid and Glucocorticoid Receptor-Mediated Transcription in Hippocampal Cells--Toward a Basis for the Opposite Actions Elicited by Two Nuclear Receptors?
Mol. Pharmacol., March 1, 2004; 65(3): 761 - 769.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
A. Rascle, J. A. Johnston, and B. Amati
Deacetylase Activity Is Required for Recruitment of the Basal Transcription Machinery and Transactivation by STAT5
Mol. Cell. Biol., June 15, 2003; 23(12): 4162 - 4173.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
J. R. Lambert and S. K. Nordeen
CBP Recruitment and Histone Acetylation in Differential Gene Induction by Glucocorticoids and Progestins
Mol. Endocrinol., June 1, 2003; 17(6): 1085 - 1094.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
Q. Li, A. Su, J. Chen, Y. A. Lefebvre, and R. J. G. Hache
Attenuation of Glucocorticoid Signaling through Targeted Degradation of p300 via the 26S Proteasome Pathway
Mol. Endocrinol., December 1, 2002; 16(12): 2819 - 2827.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
Z. Yu, W. Zhang, and B. C. Kone
Histone Deacetylases Augment Cytokine Induction of the iNOS Gene
J. Am. Soc. Nephrol., August 1, 2002; 13(8): 2009 - 2017.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2002 by the American Society for Biochemistry and Molecular Biology.